BioGX and Bosch Healthcare Solutions announce partnership to develop Infectious disease tests for the Vivalytic platform

Publisher: The Insight Partners

BioGX and Bosch Healthcare Solutions have partnered to develop point-of-care infectious disease tests for the Bosch Vivalytic all-in-one platform. 

Vivalytic is a universal sample-to-result platform for molecular diagnostics which can be used at the point-of-need. The patient sample is placed into the test cartridge, which is then inserted into the Vivalytic analyzer. Since the cartridge already contains all the necessary reagents, the test can be conducted with full automation and a faster turnaround time. 

Under the terms of the partnership, BioGX will develop, manufacture and supply reagents for the Vivalytic cartridges.  The two companies will collaborate to seek country specific regulatory approvals for in vitro diagnostics use.  BioGX will also provide custom reagents manufacturing service for Vivalytic open system users.

"BioGX Sample-Ready reagents and the all-in-one Bosch Vivalytic platform are a perfect match.  Our partnership with Bosch gets us a step closer to enabling the most comprehensive infectious disease portfolio for fully automated sample-to-result molecular diagnostics", said Shahin Iqbal, Ph.D., SVP of Global Operations of BioGX.